| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
52,775,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
1,247,701 |
Avg
Vol: |
599,363 |
| 52
Week Range: |
$10.49 - $10.49 |
|
| Level
I Sector: |
Information Technology |
| Level
II Sector: |
Electronics |
| Level
III Sector: |
Scientific & Technical Instruments |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-31 |
2023-12-29 |
2023-06-30 |
2022-06-30 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Manyak David M |
Exec VP, Drug Discovery Svcs |
• – – |
2006-12-15 |
4 |
D |
$5.50 |
$218,827 |
D/D |
(39,500) |
555,838 |
|
- |
|
| Manyak David M |
Exec VP, Drug Discovery Svcs |
• – – |
2006-12-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,500 |
595,338 |
|
- |
|
| Manyak David M |
Exec VP, Drug Discovery Svcs |
• – – |
2006-11-30 |
4 |
S |
$5.51 |
$49,242 |
D/D |
(8,882) |
518,991 |
|
- |
|
| Manyak David M |
Exec VP, Drug Discovery Svcs |
• – – |
2006-11-28 |
4 |
S |
$5.50 |
$226,393 |
D/D |
(41,118) |
527,973 |
|
- |
|
| Manyak David M |
Exec VP, Drug Discovery Svcs |
• – – |
2006-11-16 |
4 |
D |
$5.60 |
$8,736 |
D/D |
(1,560) |
568,991 |
|
- |
|
| Higgins Thomas T |
Chief Financial Officer |
• – – |
2006-10-10 |
4 |
D |
$4.73 |
$4,697 |
D/D |
(993) |
16,455 |
|
- |
|
| Manyak David M |
Exec VP, Drug Discovery Svcs |
• – – |
2006-10-03 |
4 |
A |
$0.00 |
$0 |
D/D |
86,847 |
605,838 |
|
- |
|
| Creager Stephen E |
VP and General Counsel |
• – – |
2006-08-17 |
4/A |
D |
$5.00 |
$6,035 |
D/D |
(1,207) |
10,840 |
|
- |
|
| Mcaree Peter F |
Vice President of Finance |
• – – |
2006-08-17 |
4 |
D |
$5.00 |
$1,985 |
D/D |
(397) |
25,550 |
|
- |
|
| Creager Stephen E |
VP and General Counsel |
• – – |
2006-08-17 |
4 |
D |
$5.00 |
$6,035 |
D/D |
(1,207) |
12,047 |
|
- |
|
| Higgins Thomas T |
Chief Financial Officer |
• – – |
2006-08-17 |
4 |
D |
$5.00 |
$5,360 |
D/D |
(1,072) |
14,323 |
|
- |
|
| Bal Bruce J |
VP, Operations & Service |
• – – |
2006-08-17 |
4 |
D |
$5.00 |
$5,360 |
D/D |
(1,072) |
38,762 |
|
- |
|
| Carter David Warren |
Director |
– • – |
2006-08-09 |
4/A |
A |
$0.00 |
$0 |
I/I |
98,313 |
37,978 |
|
- |
|
| Carter David Warren |
Director |
– • – |
2006-08-09 |
4/A |
A |
$0.00 |
$0 |
D/D |
112,090 |
112,090 |
|
- |
|
| Hrusovsky E Kevin |
President & CEO |
• • – |
2006-08-09 |
4 |
A |
$4.25 |
$27,060 |
D/D |
6,367 |
163,013 |
|
- |
|
| Creager Stephen E |
VP and General Counsel |
• – – |
2006-07-30 |
4 |
D |
$4.42 |
$10,670 |
D/D |
(2,414) |
8,672 |
|
- |
|
| Bal Bruce J |
VP, Operations & Service |
• – – |
2006-07-30 |
4 |
D |
$4.42 |
$9,476 |
D/D |
(2,144) |
36,459 |
|
- |
|
| Mcaree Peter F |
Vice President of Finance |
• – – |
2006-07-30 |
4 |
D |
$4.42 |
$6,316 |
D/D |
(1,429) |
24,697 |
|
- |
|
| Higgins Thomas T |
Chief Financial Officer |
• – – |
2006-07-10 |
4 |
D |
$4.34 |
$4,310 |
D/D |
(993) |
12,020 |
|
- |
|
| Higgins Thomas T |
Chief Financial Officer |
• – – |
2006-04-10 |
4 |
D |
$6.05 |
$6,008 |
D/D |
(993) |
9,888 |
|
- |
|
| Manyak David M |
Exec VP, Drug Discovery Svcs |
• – – |
2006-03-14 |
4 |
S |
$6.55 |
$328,174 |
D/D |
(50,000) |
565,551 |
|
- |
|
| Platinum Asset Management Ltd |
10% Owner |
– – • |
2006-03-08 |
4 |
B |
$6.70 |
$587,356 |
I/I |
87,665 |
3,452,939 |
1.5 |
- |
|
| Platinum Asset Management Ltd |
10% Owner |
– – • |
2006-03-06 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,365,274 |
|
- |
|
| Higgins Thomas T |
officerTitle |
• – – |
2006-01-10 |
4 |
D |
$5.95 |
$28,227 |
D/D |
(4,744) |
7,756 |
|
- |
|
| Manyak David M |
Exec VP, Drug Discovery SvcsOf |
• – – |
2005-10-03 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
12,060 |
|
- |
|
291 Records found
|
|
Page 11 of 12 |
|
|
